ask="11.00"
ask_size="400"
average_daily_volume="30316"
bid="3.12"
bid_size="100"
book_value="3.34"
change="+1.29"
change_from_200_day_moving_average="3.16"
change_from_50_day_moving_average="2.39"
change_from_52_week_high="0.00"
change_From_52_week_low="6.27"
change_in_percent="+15.18%"
close="9.79"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.60"
eps_estimate_next_quarter="-0.63"
eps_estimate_next_year="-2.85"
ex_dividend_date="N/A"
float_shares="686000"
high="9.79"
high_52_weeks="9.79"
last_trade_date="2/9/2017"
last_trade_price="9.79"
last_trade_size="112"
last_trade_time="4:00pm"
low="8.79"
low_52_weeks="3.52"
market_capitalization="208.33M"
moving_average_200_day="6.63"
moving_average_50_day="7.40"
name="Nabriva Therapeutics AG"
notes="N/A"
one_year_target_price="16.25"
open="8.79"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+47.66%"
percent_change_from_50_day_moving_average="+32.24%"
percent_change_from_52_week_high="+0.00%"
percent_change_from_52_week_low="+178.12%"
previous_close="8.50"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.54"
price_per_sales="34.78"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.92"
stock_exchange="NMS"
symbol="NBRV"
volume="35595"
weeks_range_52="3.52 - 9.79"
